Comprehensive and quality medicine transport
The Arola’s Quality Plan for Medicines for Human Use, which was developed at the initiative of its transport division, is aimed at providing the pharmaceutical companies with a methodological tool enabling them to comply with Good Distribution Practice for Medicines and to have the necessary guarantees of product’s control and traceability during its international transport. Basically it involves the common methodology development for all services of Arola, both internal and outsourced, transport, customs and infrastructural which at the same time are involved to maintain the quality of its product. The implementation of this plan has a clear institutional support from some major international laboratories which are already taking advantage of it.
The Quality Plan for Medicines establishes the following actions for its consolidation:
- Supporting the creation of the quality systems of different providers of international transport services for pharmaceutical products.
- Creation of a single channel for its communication and compliance
- Consolidation of Arola as a sole managing agent from the production point of the product to its consumption.
- Supporting the recognition and diffusion in Spanish pharmaceutical business organizations and international standardization bodies.
Compared to previous experiences in quality systems of inter-sectoral applicability level, the development of the set of all the elements of this new system, as being specifically designed for the pharmaceutical industry, represents a pioneer experience, both nationally and internationally.
Quality, competitiveness, profitability and sustainability are the concepts that are intrinsically related within the established plan of actions. Therefore, the focus on the Good Distribution Practice compliance and its continuous improvement have led to the establishment of a quality system, in which, in addition to assumption of the needs of the regulation and its services, it is taken into consideration the international applicability of its management as a differentiating factor which, in regard to the pharmaceutical companies, does not need additional technical and human structure dedicated to its achievement.
Finally, the communication to the clients of the achievements obtained through its compliance will also help make the effort to achieve continuous improvement in their companies.